动脉瘤性蛛网膜下腔出血WFNS I级患者的不良结局
这项前瞻性队列研究纳入2011年12月至2016年1月期间连续收治的132例WFNS I级动脉瘤性蛛网膜下腔出血患者,最终分析116例,用6个月改良Rankin量表评估结局。22%患者结局不良,8%死亡,年龄、迟发性脑缺血、肺炎和脑膜炎与不良结局相关。
要点
- WFNS I级aSAH患者中22%在6个月时结局不良(mRS 3-6分)。
- 仅4%患者mRS为0分,65%为2分,8%死亡。
- 年龄、迟发性脑缺血、肺炎和脑膜炎与不良结局相关。
核心结论
- 尽管入院时神经功能状态良好,约五分之一WFNS I级aSAH患者在6个月随访时临床结局不良或死亡。
研究设计与样本
- 前瞻性队列研究,2011年12月至2016年1月连续纳入132例18岁及以上WFNS I级aSAH患者,最终分析116例,6个月随访用mRS评估结局,不良结局定义为mRS 3-6分,采用logistic回归进行单变量分析。
主要发现
- 116例患者中仅5例(4%)mRS为0分,大多数(65%)mRS为2分,25例(22%)结局不良,9例(8%)死亡,其中4例在住院期间死亡。
- 与不良结局相关的因素包括年龄(每增加10岁:OR 1.78,95%CI 1.16-2.72)、迟发性脑缺血(OR 4.32,95%CI 1.63-11.44)、肺炎(OR 10.75,95%CI 1.94-59.46)和脑膜炎(OR 28.47,95%CI 1.42-571.15)。
局限性
- 需要在更大的患者队列中进行多变量分析,以确定可预防的并发症对这些患者不良结局的贡献程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with an aneurysmal subarachnoid hemorrhage (aSAH) and World Federation of Neurosurgical Societies (WFNS) grade I on admission are generally considered to have a good clinical outcome. OBJECTIVE: The objective of this study was to assess the actual clinical outcome of WFNS grade I aSAH patients, and to determine which factors are associated with unfavourable outcome. METHODS: For this prospective cohort study, 132 consecutive patients (age 18 years or older) with a WFNS grade I aSAH admitted to our hospital between December 2011 and January 2016 were eligible. Clinical outcome was measured using the modified Rankin Scale (mRS) at 6-month follow-up. Unfavorable outcome was defined as an mRS score of 3-6. Univariable analyses were performed using logistic regression models. RESULTS: Of 116 patients, only 5 patients (4%) had an mRS score of 0 and most (65%) had an mRS score of 2. Twenty-five patients (22%) had an unfavorable outcome. Nine (8%) patients died, of whom 4 died during admission. Factors associated with unfavorable outcome were age (per increasing decade: odds ratio [OR]. 1.78; 95% confidence interval [CI], 1.16-2.72), delayed cerebral ischemia (OR, 4.32; 95% CI, 1.63-11.44), pneumonia (OR, 10.75; 95% CI, 1.94-59.46) and meningitis (OR, 28.47; 95% CI, 1.42-571.15). CONCLUSIONS: Despite their neurologically optimal clinical condition on admission, 1 in 5 patients with WFNS grade I aSAH has an unfavorable clinical outcome or is dead at 6-month follow-up. Additional multivariable analysis in larger patient cohorts is necessary to identify the extent to which preventable complications contribute to unfavorable outcomes in these patients.
引用
- Zijlmans JL, Coert BA, van den Berg R, et al. Unfavorable Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage WFNS Grade I. World Neurosurg. 2018. PMID: 29966780. doi:10.1016/j.wneu.2018.06.157
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。